Institutional investors purchased a net $398.4 thousand shares of GENE during the quarter ended June 2017, and now own 0.00% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ALPINE GLOBAL MANAGEMENT LLC Bought 70.7 Thousand shares of Genetic Technologies Ltd